In-silico characterization of ECE-1 inhibitors

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Computational Biology

Background:

• Atherosclerosis is a major contributor to coronary artery disease (CAD) and cerebrovascular disease.
• Endothelin (ET)-1, a vasoconstrictive peptide, plays a significant role in the pathology of atherosclerosis.
• Endothelin-converting enzyme (ECE) is a key metalloprotease responsible for generating ET-1.

Purpose of the Study:

• To identify and characterize potent inhibitors of endothelin-converting enzyme-1 (ECE-1).
• To computationally screen existing ECE-1 inhibitors and discover novel compounds with therapeutic potential for atherosclerosis and related diseases.

Main Methods:

• Literature review to gather reported ECE-1 inhibitors and their IC(50) values.
• Molecular docking simulations using Molegro virtual docker to assess binding affinity (MolDock scores).
• Graphical analysis of IC(50) values against MolDock scores to identify potent inhibitors.
• ZINC database search for compounds with similar structural and property profiles.

Main Results:

• Successfully docked reported ECE-1 inhibitors and obtained their MolDock scores.
• Established a correlation between IC(50) values and MolDock scores for inhibitor characterization.
• Identified potent ECE-1 inhibitors with high Dock scores and favorable rankings through database searching.

Conclusions:

• The study successfully identified potent ECE-1 inhibitors using a combination of computational methods.
• The identified compounds show promise as therapeutic agents for atherosclerosis and cardiovascular diseases.
• Further investigation of these compounds could lead to novel treatments for conditions associated with ET-1 dysregulation.